GLOBOCAN Cancer Fact Sheets: colorectal Cancers. 2012. [Online]. Available: http://globocan.iarc.fr/old/FactSheets/cancers/colorectal-new.asp. Accessed 4 Mar 2017.
“National Program for Quality Indicators in Community Health care 2013–2015,” 2015. [Online]. Available: http://www.israelhpr.org.il/1043/470.htm.
Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM. Time to colonoscopy after positive fecal blood test in four U.S. health care systems. Cancer Epidemiol Biomark Prev. 2016;25(2):344–50.
Article
Google Scholar
Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH, Parkerton PH, Asch SM. Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Nectum. 2006;49(7):1002–10.
Article
Google Scholar
Meester RGS, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, Dominitz JA, Levin TR, Corley DA, Lansdorp-Vogelaar I. Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal Cancer screening test. Clin Gastroenterol Hepatol. 2016;14(10):1445–1451.e8.
Article
Google Scholar
Meester RGS, Doubeni CA, Lansdorp-Vogelaar I, Goede SLL, Levin TR, Quinn VP, van Ballegooijen M, Corley D a, Zauber AG. Colorectal Cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2014;3:208–13.
Google Scholar
Charlie H Viiala KM, Tang KW, Lawrance IC, Olynyk JK. Waiting times for colonoscopy and colorectal cancer diagnosis. Med J Aust. 2007;186(6):282–5.
PubMed
Google Scholar
Choi KS, Lee H-Y, Jun JK, Shin A, Park E-C. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J Gastroenterol Hepatol. 2012;27(6):1070–7.
Article
Google Scholar
Liss DT, Brown T, Lee JY, Altergott M, Buchanan DR, Newland A, Park JN, Rittner SS, Baker DW. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients. Cancer Causes Control. 2016;27(7):881–7.
Article
Google Scholar
Oluloro A, Petrik AF, Turner A, Kapka T, Rivelli J, Carney PA, Saha S, Coronado GD. Timeliness of colonoscopy after abnormal fecal test results in a safety net practice. J Community Health. 2016;41(4):864–70.
Article
Google Scholar
Paterson WG, Depew WT, Paré P, Petrunia D, Switzer C, Veldhuyzen van Zanten SJ, Daniels S, Meddings J, Barkun A, Bridges R, Dhalla S, Flook N, Gould M, Gray J, Hassoun Z, Leddin D, Lightfoot P, Mackie W, Marcon P, Moayyedi P, de la Rey Nel J, Nelles S, Sadowski D, Sylwestrowicz T, Targownik L, Tavenor A, Wilson M, McGeough L. Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol. 2006;20(6):411–23.
Article
Google Scholar
Steele RJC, McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NAG, Wilson JA, Kenicer M, Carey FA, Fraser CG. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut. 2008;58(4):530–5.
Article
Google Scholar
Singh H, a Petersen L, Daci K, Collins C, Khan M, El-Serag HB. Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? Qual {&} Saf Heal care. 2010;19(5):1–6.
Google Scholar
“National Program for Quality Indicators in Community Health Care in Israel 2012–2014,” 2014. [Online]. Available: http://www.israelhpr.org.il/1043/470.htm.
Johnson MR, Grubber J, Grambow SC, Maciejewski ML, Dunn-Thomas T, Provenzale D, Fisher DA. Physician non-adherence to colonoscopy interval guidelines in the veterans affairs healthcare system. Gastroenterology. 2015;149(4):938–51.
Article
Google Scholar
Bujanda L, Sarasqueta C, Zubiaurre L, Cosme A, Muñoz C, Sánchez A, Martín C, Tito L, Piñol V, Castells A, Llor X, Xicola RM, Pons E, Clofent J, De Castro ML, Cuquerella J, Medina E, Gutierrez A, Arenas JI, Jover R. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007;56(12):1714–8.
Article
Google Scholar
Garcia G, Riechelmann R, Hoff P. Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer. Clinics. 2015;70(10):696–9.
Article
Google Scholar
May FP, Bromley EG, Reid MW, Baek M, Yoon J, Cohen E, Lee A, Van Oijen MGH, Spiegel BMR. Low uptake of colorectal cancer screening among African Americans in an integrated veterans affairs health care network. Gastrointest Endosc. 2014;80(2):291–8.
Article
Google Scholar
Jibara G, Jandorf L, Fodera MB, DuHamel KN. Adherence to physician recommendation to colorectal cancer screening colonoscopy among Hispanics. J Gen Intern Med. 2011;26(10):1124–30.
Article
Google Scholar
Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(9):1602–10.
Article
Google Scholar
Hay JL, Ramos M, Li Y, Holland S, Brennessel D, Kemeny MM. Deliberative and intuitive risk perceptions as predictors of colorectal cancer screening over time. J Behav Med. 2016;39(1):65–74.
Article
Google Scholar
Bronner K, Mesters I, Weiss-Meilik A, Geva R, Rozner G, Strul H, Inbar M, Halpern Z, Kariv R. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer. Patient Educ Couns. 2013;93(2):272–81.
Article
Google Scholar
J. H. Hibbard, E. R. Mahoney, J. Stockard, and M. Tusler, “Development and testing of a short form of the patient activation measure,” Health Serv Res, vol. 40, no. 6, part I, pp. 1918–1930, 2005.
Article
Google Scholar
Hibbard JH, Mahoney E. Toward a theory of patient and consumer activation. Patient Educ Couns. 2010;78(3):377–81.
Article
Google Scholar
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39, no. 4 Partt 1, pp:1005–26.
Article
Google Scholar
Green BB, Wang CY, Horner K, Catz S, Meenane RT, Richard T, Meenane P, Vernon SW. PhDf, David Carrell, PhDb, Jessica Chubak, and Ms. Cynthia Ko, MD, MPHc, Sharon Laing, PhDg, and Andy Bogart, Systems of Support to increase colorectal Cancer screening and follow-up rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010;31(6):589–603.
Article
Google Scholar
Saft HL, Kilaru S, Moore E, Enriquez M. The impact of a patient activation measure on asthma outcomes: a pilot study. Chest. 2008;134, no. 4_MeetingAbstracts, p. s2004:2S.
Article
Google Scholar
Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease-management by tailoring care to the Patient’s level of activation. Am J Manag Care. 2009;15(6):353–60.
PubMed
Google Scholar
Mosen J, David M, Schmittdiel J, Judith H, Sobel D, Remmers C. Bellows, “is patient activation associated with outcomes of Care for Adults with chronic conditions?,”. J Ambul Care Manag. 2007;30(1):21–9.
Article
Google Scholar
Skolasky RL, Mackenzie EJ, RileyIII LH, Wegener ST. Psychometric properties of the patient activation measure among individuals presenting for elective lumbar spine surgery. Qual Life Res. 2009;18(10):1357–66.
Article
Google Scholar
Stepleman L, Rutter M-C, Hibbard J, Johns L, Wright D, Hughes M. Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care. Disabil Rehabil. 2010;32(19):1558–67.
Article
Google Scholar
Hendriks SH, Hartog LC, Groenier KH, Maas AHEM, van Hateren KJJ, Kleefstra N, Bilo HJG. Patient activation in type 2 diabetes: does it differ between men and women? J Diabetes Res. 2016;2016:7386532.
Article
Google Scholar
Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520–6.
Article
Google Scholar
“Israel Central Bureau of Statistics.” [Online]. Available: http://www.cbs.gov.il/reader/.
Magnezi R, Glasser S. Psychometric properties of the Hebrew translation of the patient activation measure (PAM-13). PLoS One. 2014;9(11):e113391.
Article
Google Scholar
Patient Activation Measure Tool and P. A. M. Tool, “{©} insignia health , LLC 2013,” pp. 1–9, 2013.
Mazanec SR, Sattar A, Delaney CP, Daly BJ. Activation for health Management in Colorectal Cancer Survivors and Their Family Caregivers. West J Nurs Res. 2016;38(3):325–44.
Article
Google Scholar
Graffigna G, Barello S, Bonanomi A. The role of patient health engagement model (PHE-model) in affecting patient activation and medication adherence: a structural equation model. PLoS One. 2017;12(6):1–19.
Article
Google Scholar
Hibbard JH, Greene J, Shi Y, Mittler J, Scanlon D. Taking the long view: how well do patient activation scores predict outcomes four years later? Med Care Res Rev. 2015;72(3):324–37.
Article
Google Scholar
Azaiza F, Cohen M. Colorectal cancer screening, intentions, and predictors in Jewish and Arab Israelis: a population-based study. Heal Educ Behav. 2008;35(4):478–93.
Article
Google Scholar
Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–87.
Article
Google Scholar
Gupta S, Brenner AT, Ratanawongsa N, Inadomi JM. Patient trust in physician influences colorectal cancer screening in low-income patients. Am J Prev Med. 2014;47(4):417–23.
Article
Google Scholar
Hudson SV, Ferrante JM, Ohman-Strickland P, Hahn K a, Shaw EK, Hemler J, Crabtree BF. Physician recommendation and patient adherence for colorectal cancer screening. J Am Board Fam Med. 2012;25(6):782–91.
Article
Google Scholar
Dawson G, Crane M, Lyons C, Burnham A, Bowman T, Perez D, Travaglia J. General practitioners’ perceptions of population based bowel screening and their influence on practice: a qualitative study. BMC Fam Pract. 2017;18(1):1–7.
Article
Google Scholar
Sahin MK. Barriers to colorectal Cancer screening in a primary care setting in Turkey. J Community Health. 2017;42(1):101–8.
Article
Google Scholar